APA (7th ed.) Citation

Aliprantis, A. O., Shaw, C. A., Griffin, P., Farinola, N., Railkar, R. A., Cao, X., . . . Panther, L. (2021). A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Human vaccines & immunotherapeutics, 17(5), 1248-1261. https://doi.org/10.1080/21645515.2020.1829899

Chicago Style (17th ed.) Citation

Aliprantis, Antonios O., et al. "A Phase 1, Randomized, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of an MRNA-based RSV Prefusion F Protein Vaccine in Healthy Younger and Older Adults." Human Vaccines & Immunotherapeutics 17, no. 5 (2021): 1248-1261. https://doi.org/10.1080/21645515.2020.1829899.

MLA (9th ed.) Citation

Aliprantis, Antonios O., et al. "A Phase 1, Randomized, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of an MRNA-based RSV Prefusion F Protein Vaccine in Healthy Younger and Older Adults." Human Vaccines & Immunotherapeutics, vol. 17, no. 5, 2021, pp. 1248-1261, https://doi.org/10.1080/21645515.2020.1829899.